APMA's outreach and collaboration with the American Public Health Association (APHA) has yielded an important victory. APHA's Foot and Ankle Section recently submitted a strong letter of support urging Massachusetts lawmakers to advance House Bill 2407 and Senate Bill 1542. This endorsement underscores the critical role of podiatrists in preventing diabetes complications, reducing amputations, and expanding access to high-quality foot and ankle care.
While Congress was away for August recess, APMA's government affairs team spent the month laying the groundwork with congressional staff to make sure podiatric priorities are front and center in September.
Following the release of the new Wasteful and Inappropriate Service Reduction (WISeR) Model by the CMS, APMA promptly engaged with CMS to share the association's concerns and provide its recommendations. Now, House Democratic lawmakers, led by Representatives Susan DelBene (D-WA-01) and Ami Bera, MD (D-CA-06), have sent a letter seeking further information on WISeR from CMS as well.
APMA recently submitted comments to the U.S. House Committee on Ways & Means in response to its joint Subcommittee hearing titled Medicare Advantage: Past Lessons, Present Insights, Future Opportunities. APMA's comments highlighted ongoing challenges faced by podiatrists with Medicare Advantage (MA) plans and offered concrete solutions for Congress to address them.
APMA is the organization advocating for podiatric physicians and surgeons on Capitol Hill, with CMS and private payers, and with the public. To keep our members informed about all the advocacy work being accomplished, APMA released Advocacy in Action: APMA Advocacy Impact Report, 2025 Mid-Year Update. This report is a comprehensive summary of the important legislative and policy work that APMA is doing on behalf of podiatrists.
As APMA previously shared, CMS released the Medicare Physician Fee Schedule for Calendar Year 2026 proposed rule. A summary of the proposed rule and further analysis conducted by APMA is now available online.
Two APMA members participated in the Clinician Expert Workgroup (CEW) for the Non-Pressure Ulcers episode-based cost measure last week: APMA Coding Committee Chair David Freedman, DPM, and APMA Vice President, Clinical Affairs and Medical Director Dyane Tower, DPM, MPH, MS, CAE. Dr. Tower serves as Co-Chair for the CEW.
APMA is pleased to announce the winners of the APMA 2025 Annual Scientific Meeting Abstract Competition. The winners in each category were selected by a panel of judges appointed by the Education Committee.
As a result of APMA's advocacy, the episode-based cost measure related to Non-Pressure Ulcers, for potential use in the Merit-based Incentive Payment System (MIPS), was not part of the recently released Medicare Physician Fee Schedule for Calendar Year 2026 proposed rule.
The Centers for Medicare & Medicaid Services (CMS) recently unveiled a new initiative—the Wasteful and Inappropriate Service Reduction (WISeR) Model—designed to target services within Medicare that are considered vulnerable to fraud, waste, and abuse. APMA Health Policy Advisor Jeffrey Lehrman, DPM, recorded a brief video to help podiatrists better understand the ramifications of this new model.
Last week, APMA submitted a sign-on letter to Cigna, urging it to rescind its problematic Modifier 50 reimbursement policy as it relates to bilateral imaging. This APMA-led letter was also signed on by the American Academy of Orthopaedic Surgeons and five other orthopedic specialty societies.
Last week, APMA responded to the Department of Health and Human Services’ (HHS) "Request for Information (RFI): Ensuring Lawful Regulation and Unleashing Innovation To Make American Healthy Again," calling on HHS to remove or reduce burdens related to same or similar requirements for durable medical equipment (DME), duplicative certification requirements for the Medicare Therapeutic Shoes for Diabetics (TSD) program, and the Merit-based Incentive Payment System.
Yesterday, the Massachusetts Legislature's Joint Committee on Public Health met to hear testimony from podiatric physicians and other allies in support of the Massachusetts Foot and Ankle Society’s (MFAS) legislation that would modernize the state podiatric scope of practice. Massachusetts is one of only two remaining states that do not permit podiatrists to treat the ankle in the state statue.
CMS has issued the proposed Medicare Physician Fee Schedule for Calendar Year 2026. The annually issued rule outlines proposed changes to payment rates, telehealth services, quality reporting programs, and more. The proposed Conversion Factor is 3.62% with an estimated impact of 2 percent for podiatry. Thanks to the advocacy efforts of APMA and its members, Congress provided a 2.5-percent payment increase for 2026 in the One Big Beautiful Bill Act. Read on for more impacts for podiatrists.
The budget reconciliation bill, known as the One Big Beautiful Bill Act (OBBBA), a broad spending and tax bill that includes significant health care policies, was signed by President Trump on July 4 after passing both chambers of Congress. APMA advocated vigorously on behalf of the profession.
APMA advocacy staff met with an Aetna medical director last week to discuss ongoing member concerns and the recent commitment by Aetna and other major health insurers to simplify the prior authorization process. APMA meets with Aetna quarterly to facilitate these conversations and advocate on behalf of our members.
Last week, the CMS Innovation Center announced a new model, known as the Wasteful and Inappropriate Service Reduction Model or WISeR Model, which aims to streamline the review process for certain items and services that are vulnerable to fraud, waste, and abuse under Medicare. The model is voluntary and will run for six performance years.
Update: Congress has passed the Budget Reconciliation bill. The president is expected to sign it soon. Read more to learn how the legislation impacts podiatric physicians and surgeons, plus take a look at the priorities APMA shared with congressional leadership as they were debating the bill.
APMA continues to advocate for members as the Senate releases its version of the Budget Reconciliation Bill. The House passed H.R. 1 earlier this month, and the Senate aims to pass their version by the July 4th holiday. Take action today to support podiatry.
APMA is pleased to report that Optum has reserved its decision to reclassify podiatrists. APMA thanks Optum for recognizing that podiatrists are independently licensed physicians who undergo specialized education and training and reaffirming the vital role podiatrist play in advancing clinical outcomes and caring for their patients.